Market Tracker

07/31 6:01pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.41
Delayed Data
As of Jul 31
 -0.001 / -0.24%
Today’s Change
0.34
Today|||52-Week Range
3.98
-74.37%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.41
Today’s open0.40
Day’s range0.40 - 0.43
Volume306,108
Average volume (3 months)1,808,591
Market cap$23.5M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+72.57%
Earnings growth (this year)+68.35%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.21%
P/E ratioNM
Price/Sales368.74
Price/Book7.74

Competitors

 Today’s
change
Today’s
% change
CANFCan Fite Biopharma L...+0.05+2.62%
--Cell Source Inc0.000.00%
CBMXCombiMatrix Corp+0.02+1.42%
NSPHNanosphere Inc-0.03-1.00%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$71.0K
Annual profit (last year)-$8.8M
Net profit margin-12,394.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Westborough, Massachusetts

Forecasts